Supplemental Consolidating Data (Cash Flows) (Detail) (USD $) | 3 Months Ended |
In Thousands, unless otherwise specified | Mar. 29, 2015 | Mar. 30, 2014 |
Segment Reporting Information [Line Items] | | |
Deferred Income Taxes and Tax Credits | $2,820 | ($474) |
Cash flows from operating activities: | | |
Net income | 269,854 | 265,917 |
Adjustments to reconcile net income to net cash provided by operating activities: | | |
Depreciation | 46,028 | 43,398 |
Amortization of deferred loan origination costs | 22,932 | 22,101 |
Amortization Of Financing Origination Fees | 2,215 | 2,085 |
Pension and Other Postretirement Benefit Expense | 12,318 | 8,425 |
Contributions to pension and postretirement plans | -6,627 | -6,879 |
Stock compensation expense | 8,046 | 9,239 |
Net change in wholesale finance receivables related to sales | -465,598 | -439,422 |
Provision for credit losses | 26,247 | 20,331 |
Foreign currency adjustments | 18,154 | -4,172 |
Other, net | -2,507 | 3,055 |
Changes in current assets and liabilities: | | |
Accounts receivable | -49,936 | -61,217 |
Finance receivables-accrued interest and other | 2,067 | 793 |
Inventories | -51,934 | -20,317 |
Accounts payable and accrued liabilities | 305,102 | 356,430 |
Derivative instruments | 399 | 1,222 |
Increase (Decrease) in Prepaid Expenses, Other | -35,120 | -3,071 |
Total adjustments | -95,154 | -62,331 |
Net cash provided by operating activities | 174,700 | 203,586 |
Cash flows from investing activities: | | |
Capital expenditures | -38,069 | -25,881 |
Origination of finance receivables | -752,404 | -757,965 |
Collections of finance receivables | 729,666 | 707,431 |
Sales and redemptions of marketable securities | 0 | 6,001 |
Other | 9 | 51 |
Net cash (used by) provided by investing activities | -60,798 | -70,363 |
Repayments of Unsecured Debt | 0 | -303,000 |
Proceeds from Issuance of Medium-term Notes | 595,386 | 0 |
Cash flows from financing activities: | | |
Intercompany Borrowing Activity | 0 | |
Proceeds from Securitization Debt | 697,591 | 0 |
Repayments of Securitization Debt | -200,695 | -159,938 |
borrowings of asset backed commercial paper | 16,798 | 13,746 |
Proceeds from (Repayments of) Credit Facility and Other Unsecured Debt | -661,241 | 307,803 |
Net repayments of asset-backed commercial paper | 15,744 | |
Repayments of asset-backed commercial paper | -15,744 | -16,981 |
Net change in restricted cash | -28,579 | 26,924 |
Dividends paid | -65,467 | -60,527 |
Purchase of common stock for treasury | -192,700 | -87,690 |
Excess tax benefits from share based payments | 2,207 | 4,763 |
Issuance of common stock under employee stock option plans | 9,605 | 8,894 |
Borrowings of asset-backed commercial paper | 16,798 | 13,746 |
Net cash provided by (used by) financing activities | 157,161 | -266,006 |
Effect of exchange rate changes on cash and cash equivalents | -9,019 | 1,991 |
Net increase (decrease) in cash and cash equivalents | 262,044 | -130,792 |
Cash and cash equivalents: | | |
Cash and cash equivalents—beginning of period | 906,680 | 1,066,612 |
Net increase (decrease) in cash and cash equivalents | 262,044 | -130,792 |
Cash and cash equivalents—end of period | 1,168,724 | 935,820 |
Motorcycles And Related Products Operations [Member] | | |
Segment Reporting Information [Line Items] | | |
Deferred Income Taxes and Tax Credits | 6,594 | 3,159 |
Cash flows from operating activities: | | |
Net income | 327,249 | 347,054 |
Adjustments to reconcile net income to net cash provided by operating activities: | | |
Depreciation | 43,947 | 41,603 |
Amortization of deferred loan origination costs | 0 | 0 |
Amortization Of Financing Origination Fees | 0 | 59 |
Pension and Other Postretirement Benefit Expense | 12,318 | 8,425 |
Contributions to pension and postretirement plans | -6,627 | -6,879 |
Stock compensation expense | 7,381 | 8,550 |
Net change in wholesale finance receivables related to sales | 0 | 0 |
Provision for credit losses | 0 | 0 |
Foreign currency adjustments | 18,154 | -4,172 |
Other, net | -1,893 | -496 |
Changes in current assets and liabilities: | | |
Accounts receivable | -392,593 | -387,875 |
Finance receivables-accrued interest and other | 0 | 0 |
Inventories | -51,934 | -20,317 |
Accounts payable and accrued liabilities | 241,052 | 290,208 |
Derivative instruments | 399 | 1,222 |
Increase (Decrease) in Prepaid Expenses, Other | -27,082 | -1,770 |
Total adjustments | -96,120 | -64,743 |
Net cash provided by operating activities | 231,129 | 282,311 |
Cash flows from investing activities: | | |
Capital expenditures | -37,240 | -24,691 |
Origination of finance receivables | 0 | 0 |
Collections of finance receivables | 0 | 0 |
Sales and redemptions of marketable securities | | 6,001 |
Other | 9 | 51 |
Net cash (used by) provided by investing activities | -37,231 | -18,639 |
Repayments of Unsecured Debt | | -303,000 |
Proceeds from Issuance of Medium-term Notes | 0 | |
Cash flows from financing activities: | | |
Intercompany Borrowing Activity | 250,000 | |
Proceeds from Securitization Debt | 0 | |
Repayments of Securitization Debt | 0 | 0 |
borrowings of asset backed commercial paper | 0 | 0 |
Proceeds from (Repayments of) Credit Facility and Other Unsecured Debt | 0 | 0 |
Net repayments of asset-backed commercial paper | 0 | |
Repayments of asset-backed commercial paper | | 0 |
Net change in restricted cash | 0 | 0 |
Dividends paid | -65,467 | -60,527 |
Purchase of common stock for treasury | -192,700 | -87,690 |
Excess tax benefits from share based payments | 2,207 | 4,763 |
Issuance of common stock under employee stock option plans | 9,605 | 8,894 |
Net cash provided by (used by) financing activities | 3,645 | -437,560 |
Effect of exchange rate changes on cash and cash equivalents | -7,263 | 3,268 |
Net increase (decrease) in cash and cash equivalents | 190,280 | -170,620 |
Cash and cash equivalents: | | |
Cash and cash equivalents—beginning of period | 573,895 | 718,912 |
Net increase (decrease) in cash and cash equivalents | 190,280 | -170,620 |
Cash and cash equivalents—end of period | 764,175 | 548,292 |
Financial Services Operations [Member] | | |
Segment Reporting Information [Line Items] | | |
Deferred Income Taxes and Tax Credits | -3,774 | -3,633 |
Cash flows from operating activities: | | |
Net income | 42,605 | 38,863 |
Adjustments to reconcile net income to net cash provided by operating activities: | | |
Depreciation | 2,081 | 1,795 |
Amortization of deferred loan origination costs | 22,932 | 22,101 |
Amortization Of Financing Origination Fees | 2,215 | 2,026 |
Pension and Other Postretirement Benefit Expense | 0 | 0 |
Contributions to pension and postretirement plans | 0 | 0 |
Stock compensation expense | 665 | 689 |
Net change in wholesale finance receivables related to sales | 0 | 0 |
Provision for credit losses | 26,247 | 20,331 |
Foreign currency adjustments | 0 | 0 |
Other, net | -614 | 3,551 |
Changes in current assets and liabilities: | | |
Accounts receivable | 0 | 0 |
Finance receivables-accrued interest and other | 2,067 | 793 |
Inventories | 0 | 0 |
Accounts payable and accrued liabilities | 406,607 | 392,880 |
Derivative instruments | 0 | 0 |
Increase (Decrease) in Prepaid Expenses, Other | -8,038 | -1,301 |
Total adjustments | 466,464 | 441,834 |
Net cash provided by operating activities | 509,069 | 480,697 |
Cash flows from investing activities: | | |
Capital expenditures | -829 | -1,190 |
Origination of finance receivables | -2,008,170 | -1,992,601 |
Collections of finance receivables | 1,519,934 | 1,502,645 |
Sales and redemptions of marketable securities | | 0 |
Other | 0 | 0 |
Net cash (used by) provided by investing activities | -489,065 | -491,146 |
Repayments of Unsecured Debt | | 0 |
Proceeds from Issuance of Medium-term Notes | 595,386 | |
Cash flows from financing activities: | | |
Intercompany Borrowing Activity | -250,000 | |
Proceeds from Securitization Debt | 697,591 | |
Repayments of Securitization Debt | -200,695 | -159,938 |
borrowings of asset backed commercial paper | 16,798 | 13,746 |
Proceeds from (Repayments of) Credit Facility and Other Unsecured Debt | -661,241 | 307,803 |
Net repayments of asset-backed commercial paper | 15,744 | |
Repayments of asset-backed commercial paper | | -16,981 |
Net change in restricted cash | -28,579 | 26,924 |
Dividends paid | -100,000 | -120,000 |
Purchase of common stock for treasury | 0 | 0 |
Excess tax benefits from share based payments | 0 | 0 |
Issuance of common stock under employee stock option plans | 0 | 0 |
Net cash provided by (used by) financing activities | 53,516 | 51,554 |
Effect of exchange rate changes on cash and cash equivalents | -1,756 | -1,277 |
Net increase (decrease) in cash and cash equivalents | 71,764 | 39,828 |
Cash and cash equivalents: | | |
Cash and cash equivalents—beginning of period | 332,785 | 347,700 |
Net increase (decrease) in cash and cash equivalents | 71,764 | 39,828 |
Cash and cash equivalents—end of period | 404,549 | 387,528 |
Consolidation, Eliminations [Member] | | |
Cash flows from investing activities: | | |
Proceeds from Issuance of Medium-term Notes | 0 | |
Consolidation, Eliminations [Member] | | |
Segment Reporting Information [Line Items] | | |
Deferred Income Taxes and Tax Credits | 0 | 0 |
Cash flows from operating activities: | | |
Net income | -100,000 | -120,000 |
Adjustments to reconcile net income to net cash provided by operating activities: | | |
Depreciation | 0 | 0 |
Amortization of deferred loan origination costs | 0 | 0 |
Amortization Of Financing Origination Fees | 0 | 0 |
Pension and Other Postretirement Benefit Expense | 0 | 0 |
Contributions to pension and postretirement plans | 0 | 0 |
Stock compensation expense | 0 | 0 |
Net change in wholesale finance receivables related to sales | -465,598 | -439,422 |
Provision for credit losses | 0 | 0 |
Foreign currency adjustments | 0 | 0 |
Other, net | 0 | 0 |
Changes in current assets and liabilities: | | |
Accounts receivable | 342,657 | 326,658 |
Finance receivables-accrued interest and other | 0 | 0 |
Inventories | 0 | 0 |
Accounts payable and accrued liabilities | -342,557 | -326,658 |
Derivative instruments | 0 | 0 |
Increase (Decrease) in Prepaid Expenses, Other | 0 | 0 |
Total adjustments | -465,498 | -439,422 |
Net cash provided by operating activities | -565,498 | -559,422 |
Cash flows from investing activities: | | |
Capital expenditures | 0 | 0 |
Origination of finance receivables | 1,255,766 | 1,234,636 |
Collections of finance receivables | -790,268 | -795,214 |
Sales and redemptions of marketable securities | | 0 |
Other | 0 | 0 |
Net cash (used by) provided by investing activities | 465,498 | 439,422 |
Repayments of Unsecured Debt | | 0 |
Cash flows from financing activities: | | |
Intercompany Borrowing Activity | 0 | |
Proceeds from Securitization Debt | 0 | |
Repayments of Securitization Debt | 0 | 0 |
borrowings of asset backed commercial paper | 0 | 0 |
Proceeds from (Repayments of) Credit Facility and Other Unsecured Debt | 0 | 0 |
Net repayments of asset-backed commercial paper | 0 | |
Repayments of asset-backed commercial paper | | 0 |
Net change in restricted cash | 0 | 0 |
Dividends paid | 100,000 | 120,000 |
Purchase of common stock for treasury | 0 | 0 |
Excess tax benefits from share based payments | 0 | 0 |
Issuance of common stock under employee stock option plans | 0 | 0 |
Net cash provided by (used by) financing activities | 100,000 | 120,000 |
Effect of exchange rate changes on cash and cash equivalents | 0 | 0 |
Net increase (decrease) in cash and cash equivalents | 0 | 0 |
Cash and cash equivalents: | | |
Cash and cash equivalents—beginning of period | 0 | 0 |
Net increase (decrease) in cash and cash equivalents | 0 | 0 |
Cash and cash equivalents—end of period | $0 | $0 |